linezolid 600 milligram film coated tablet
cipla (eu) limited - linezolid (form ii) - film coated tablet - 600 milligram - other antibacterials
escitalopram 5 milligram film coated tablet
cipla (eu) limited - escitalopram oxalate - film coated tablet - 5 milligram - selective serotonin reuptake inhibitors
escitalopram 10 milligram film coated tablet
cipla (eu) limited - escitalopram oxalate - film coated tablet - 10 milligram - selective serotonin reuptake inhibitors
escitalopram 20 milligram film coated tablet
cipla (eu) limited - escitalopram oxalate - film coated tablet - 20 milligram - selective serotonin reuptake inhibitors
ipragard 20 microgram pressurised inhalation soln
cipla (eu) limited - ipratropium bromide monohydrate - pressurised inhalation soln - 20 microgram - anticholinergics
mometasone furoate 50 mcg/acutuation nasal spray suspension
cipla (eu) limited - mometasone furoate monohydrate - nasal spray suspension - 50 mcg/acutuation - corticosteroids
latanoprost 50 micrograms/ml eye drops solution
cipla (eu) limited - latanoprost - eye drops, solution - 50 micrograms/ml - antiglaucoma preparations and miotics, prostaglandin analogues - it in indicated for reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. in paediatric patients with elevated intraocular pressure and paediatric glaucoma
montelukast 10 milligram film coated tablet
cipla (eu) limited - montelukast sodium - film coated tablet - 10 milligram - leukotriene receptor antagonists - leukotriene receptor antagonist - it is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting -agonists provide inadequate clinical control of asthma. in those asthmatic patients in whom montelukast is indicated in asthma, montelukast can also provide symptomatic relief of seasonal allergic rhinitis.
cisplatin 1 mg/ml concentrate for solution for infusion
cipla (eu) limited - cisplatin. - concentrate for solution for infusion - 1mg/ml - other antineoplastic agents, pla - for the treatment of: • advanced or metastatic testicular cancer • advanced or metastatic ovarian cancer • advanced or metastatic bladder carcinoma • advanced or metastatic squamous cell carcinoma of the head and neck • advanced or metastatic non-small cell lung carcinoma • advanced or metastatic small cell lung carcinoma
montelukast paediatric 4 milligram tablets chewable
cipla (eu) limited - montelukast sodium, montelukast - tablets chewable - 4 milligram - leukotriene receptor antagonists